B · Normal
[Vaxcyte U.S. stocks surged more than 25% before the market opened] On October 5, the U.S. stock price of Vaxcyte surged more than 25% before the market opened, after the company’s pneumococcal vaccine reached late-stage clinical trial targets.
Global market intelligence 🕐 2026-10-05 18:13
#clinical trial #vaccine #Global market intelligence #U.S. stock trends
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[India's central bank launches special oil window and regulatory measures to sup 10-10 12:05 [China emphasizes that harmonious coexistence between Russia and Ukraine is a re 10-10 12:04 [The Stock Exchange of Thailand Revises Short Selling and High-Frequency Trading 10-10 11:34 [Dozens of people were injured when the ceiling of a supermarket collapsed in So 10-10 11:21 [President of Panama: The earthquake disaster is serious and the government is c 10-10 11:01 [Chinese representative: The conflict in Yemen should be resolved within the ove 10-10 11:00

Comments

0/500
Captcha (click to refresh)
No comments yet